Lipoprotein Electrophoresis

Lipoprotein Electrophoresis is a laboratory technique that separates and quantifies lipoprotein fractions—such as chylomicrons, VLDL, IDL, LDL and HDL—based on their electrical charge and mobility. The test provides a detailed profile of lipoprotein patterns beyond a standard lipid panel, helping to identify abnormal bands (for example remnant lipoproteins or altered LDL subfractions) that influence cardiovascular risk. Offered with convenient at‑home venous sample collection across Dubai, this service delivers actionable results that support targeted cardiovascular risk assessment and personalized nutrition or treatment plans.

This test is particularly useful for people with unexplained or complex dyslipidaemia, a strong family history of premature coronary artery disease, metabolic syndrome, diabetes, or those who have atypical responses to lipid‑lowering therapy. Results inform clinicians and dietitians about specific lipoprotein abnormalities and can guide tailored dietary recommendations, pharmacotherapy adjustments, and monitoring strategies. Samples are processed by accredited UAE laboratories and results should be interpreted by your physician in the context of clinical history and standard lipid measurements.

Sample requirements typically include a venous blood draw following 10–12 hours of fasting, avoidance of alcohol and strenuous exercise 24 hours prior, and notification of any prescription or over‑the‑counter medications and supplements that might affect lipid levels. Turnaround time for reports is usually 24–72 hours depending on the laboratory; results often include relative concentrations of each fraction and interpretive comments. Do not alter prescribed medications based solely on the report—discuss findings with your healthcare provider for appropriate clinical decisions.

• Chylomicrons
• Very Low-Density Lipoprotein (VLDL)
• Intermediate-Density Lipoprotein (IDL)
• Low-Density Lipoprotein (LDL)
• High-Density Lipoprotein (HDL)
• Lipoprotein(a) [Lp(a)]

• Unexplained abnormal results on a standard lipid panel
• Premature coronary artery disease or strong family history of heart disease
• Persistent high triglycerides or suspected remnant lipoproteins
• Metabolic syndrome, diabetes, or recurrent cardiovascular events despite treatment
• Assessment before or during specialised lipid‑lowering therapy

• Detailed lipoprotein fractionation for improved cardiovascular risk stratification
• Identification of remnant and atypical lipoprotein patterns not seen on routine tests
• Supports personalised dietary and pharmacologic management plans
• Convenient at‑home blood collection across Dubai with accredited lab processing
• Actionable report for clinicians and nutritionists to guide follow‑up care

• At‑home venous blood sample collection by trained phlebotomist
• 10–12 hours fasting required prior to sample collection
• Avoid alcohol and intense exercise 24 hours before the test
• Inform the phlebotomist/physician of all current medications and supplements